Welcome to our dedicated page for Blend Labs SEC filings (Ticker: BLND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blend Labs, Inc. filings document the company’s digital banking origination business, operating results, governance, capital actions, and material corporate events. Form 8-K reports cover quarterly and annual financial results, supplemental Regulation FD materials, product and service disclosures, officer-transition matters, and board-authorized repurchases of Class A common stock.
Blend’s proxy materials describe annual meeting matters, board elections, executive compensation, stockholder voting procedures, and related governance disclosures. Recent filings also document completed corporate actions, including the sale of substantially all assets and liabilities of Title365 Company, Blend’s former title insurance business.
Blend Labs, Inc. (BLND) received an updated Schedule 13D/A from investment entities affiliated with Haveli and Brian N. Sheth, reporting a large beneficial ownership position in its Class A common stock. The Haveli reporting entities each report beneficial ownership of 65,351,876 shares of Class A common stock, representing 20.8% of the class. This stake includes 46,153,845 shares issuable upon conversion of 150,000 shares of Series A convertible preferred stock, 11,111,112 shares issuable upon exercise of warrants with a $4.50 exercise price, and 8,086,919 shares of Class A common stock. Brian N. Sheth individually reports beneficial ownership of 65,481,876 shares, or 20.9% of the class, including 8,216,919 Class A shares of which 130,000 are held in a family trust. The amendment notes that since the prior amendment, the reporting persons acquired additional Class A shares, increasing their beneficial ownership by more than one percentage point.
Blend Labs, Inc. (BLND) shareholder Brian Kneafsey has filed a Rule 144 notice to sell 25,000 shares of common stock through Charles Schwab & Co., Inc. The planned sale has an aggregate market value of $74,732.00 and is listed for execution on the NYSE around 11/17/2025. The filing indicates there are 256,119,535 shares of this class outstanding.
The 25,000 shares to be sold were acquired on 02/17/2020 via an exercise-and-hold transaction from Blend Labs, Inc., paid in cash. Over the past three months, Kneafsey has already sold 25,000 Blend Labs securities on 09/15/2025 for gross proceeds of $109,069.00 and another 25,000 on 10/15/2025 for $83,509.00. By signing, the seller represents they are not aware of any undisclosed material adverse information about Blend Labs.
Blend Labs (BLND) reported insider open‑market purchases by Haveli Brooks Aggregator, L.P. and affiliated reporting persons, who are listed as a Director and 10% Owner. On 11/10/2025 they bought 701,110 Class A shares at a weighted average price of $2.9839; on 11/11/2025 they bought 600,308 shares at $2.9986; and on 11/12/2025 they bought 953,634 shares at $3.0496.
After these transactions, the filing shows 5,931,971 shares beneficially owned indirectly, plus 130,000 shares held indirectly through a family trust. Prices reflect weighted averages with underlying trade details available upon request, as noted in the footnotes.
Blend Labs (BLND) reported Q3 results showing steady revenue and a swing to GAAP profitability. Total revenue was $32.860 million versus $33.104 million a year ago, as stronger Consumer Banking Suite offset softer Mortgage Suite. Gross profit was essentially flat, while operating loss narrowed to $4.911 million from $11.283 million on lower R&D and sales and marketing spend.
GAAP net income was $12.532 million, aided by $16.6 million of gains from a non‑marketable equity investment; net income attributable to common stockholders was $7.974 million, or $0.03 basic ($0.02 diluted) per share. Cash and cash equivalents were $55.021 million and marketable securities were $22.234 million. Deferred revenue rose to $25.325 million. Remaining performance obligations totaled $189.0 million, with approximately half expected to be recognized over the next 12 months. The Title business is classified as discontinued operations. As of October 31, 2025, Class A shares outstanding were 256,119,535 and Class B shares were 3,627,385.
Blend Labs (BLND) furnished a current report announcing it issued a press release with financial results for the fiscal quarter ended September 30, 2025 and posted supplemental investor materials on its investor relations website.
The information under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure), along with Exhibit 99.1 (press release), was furnished and is not deemed filed for purposes of Section 18 of the Exchange Act. Blend also notes it distributes material information through SEC filings, press releases, public calls/webcasts, its investor site, blog, and X account to support broad disclosure.
Blend Labs (BLND) reported an equity grant to an officer on a Form 4. The Head of Finance and Administration received 2,200,000 restricted stock units (RSUs) on October 27, 2025, each representing one share of Class A common stock.
Per the award terms, 25% vests on August 20, 2026, with the remainder vesting in equal quarterly installments over the following three years, contingent on continued service. Following the grant, 2,200,000 derivative securities were reported as directly owned.
Blend Labs (BLND): insider equity change reported. A director and officer (Head of Blend) reported a transaction on 10/29/2025. The filing shows 371,000 shares of Class A Common Stock were acquired at a price of $0 under transaction code J, with total Class A beneficial ownership at 6,428,300 shares directly after the transaction.
The related note states that upon conversion of shares of Class B Common Stock, an equal number of Class A shares were pledged as collateral to secure certain personal indebtedness. Following the event, the reporting person also held 2,756,385 shares of Class B Common Stock, which are convertible into Class A on a one-for-one basis and have no expiration date.
Blend Labs (BLND) disclosed an insider transaction by its Head of Legal and People. On 10/20/2025, the reporting person sold 4,000 Class A shares at $3.50 per share under a Rule 10b5-1 trading plan adopted on March 14, 2025. Following the sale, the insider beneficially owned 380,631 shares, held directly.
Blend Labs (BLND) reported an insider transaction by its Head of Revenue. On 10/15/2025, the reporting person sold 25,000 shares of Class A common stock at a $3.3403 weighted average price, with individual trades ranging from $3.33 to $3.385. The sales were made under a Rule 10b5-1 trading plan adopted on March 14, 2025. Following the transaction, the insider beneficially owns 687,909 shares, held directly.
Blend Labs (BLND) received a Form 144 notice indicating an intended sale of 25,000 shares of common stock through Charles Schwab & Co., Inc. with an aggregate market value of $83,509, targeting an approximate sale date of October 15, 2025 on the NYSE. The form lists 255,696,747 shares outstanding.
The seller acquired these 25,000 shares on February 17, 2020 via “Exercise and Hold,” paid in cash. Recent activity disclosed three prior sales of 25,000 shares each on July 15, 2025 ($90,829), August 15, 2025 ($71,873), and September 15, 2025 ($109,069), by Brian Kneafsey.